ETF Analysts Expect 22% Upside for Vanguard Russell 2000 Growth ETF (VTWG)
ByAinvest
Friday, Jul 25, 2025 7:51 am ET1min read
ADCT--
The VTWG ETF's high target price is driven by the substantial upside analysts expect from its underlying holdings. scPharmaceuticals Inc (SCPH), Dakota Gold Corp (DC), and ADC Therapeutics SA (ADCT) are among the top contributors to VTWG's potential. SCPH, DC, and ADCT have analyst target prices that imply a 153.87%, 167.35%, and 152.18% upside from their recent prices, respectively.
Similarly, FVAL's target price is influenced by the analyst expectations for its holdings. United Airlines Holdings Inc (UAL), Amdocs Ltd (DOX), and Freeport-McMoRan Inc (FCX) are among the key contributors. UAL, DOX, and FCX have analyst target prices that imply a 20.54%, 16.15%, and 14.05% upside from their recent prices, respectively.
While these target prices suggest optimism about the future performance of these companies, it is essential for investors to conduct further research. Analyst targets can reflect a relic of the past or be a precursor to target price downgrades if the targets were overly optimistic. Investors should consider recent company and industry developments when evaluating these target prices.
References:
[1] https://www.nasdaq.com/articles/math-shows-fval-can-go-72
[2] https://www.business-standard.com/markets/news/stocks-to-buy-in-falling-market-nmdc-godrej-agro-2-others-may-gain-19-125072500675_1.html
[3] https://seekingalpha.com/news/4471824-dakota-gold-files-250m-mixed-securities-shelf
DC--
DOX--
FCX--
FVAL--
The Vanguard Russell 2000 Growth ETF (VTWG) has an implied analyst target price of $260.95 per unit, indicating 22.20% upside from its recent trading price of $213.55. Three of VTWG's underlying holdings with notable upside to their analyst target prices are scPharmaceuticals Inc (SCPH), Dakota Gold Corp (DC), and ADC Therapeutics SA (ADCT), with upside ranging from 153.87% to 167.35% from their recent prices.
Analysts have set high target prices for the Vanguard Russell 2000 Growth ETF (VTWG) and the Fidelity Value Factor ETF (FVAL), indicating significant upside potential for both ETFs. VTWG has an implied analyst target price of $260.95 per unit, a 22.20% increase from its recent trading price of $213.55. Meanwhile, FVAL's implied analyst target price is $71.55 per unit, a 9.63% increase from its recent price of $65.27.The VTWG ETF's high target price is driven by the substantial upside analysts expect from its underlying holdings. scPharmaceuticals Inc (SCPH), Dakota Gold Corp (DC), and ADC Therapeutics SA (ADCT) are among the top contributors to VTWG's potential. SCPH, DC, and ADCT have analyst target prices that imply a 153.87%, 167.35%, and 152.18% upside from their recent prices, respectively.
Similarly, FVAL's target price is influenced by the analyst expectations for its holdings. United Airlines Holdings Inc (UAL), Amdocs Ltd (DOX), and Freeport-McMoRan Inc (FCX) are among the key contributors. UAL, DOX, and FCX have analyst target prices that imply a 20.54%, 16.15%, and 14.05% upside from their recent prices, respectively.
While these target prices suggest optimism about the future performance of these companies, it is essential for investors to conduct further research. Analyst targets can reflect a relic of the past or be a precursor to target price downgrades if the targets were overly optimistic. Investors should consider recent company and industry developments when evaluating these target prices.
References:
[1] https://www.nasdaq.com/articles/math-shows-fval-can-go-72
[2] https://www.business-standard.com/markets/news/stocks-to-buy-in-falling-market-nmdc-godrej-agro-2-others-may-gain-19-125072500675_1.html
[3] https://seekingalpha.com/news/4471824-dakota-gold-files-250m-mixed-securities-shelf

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet